These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 17437504

  • 1. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization.
    Weng X, Liu L, Barcellos LF, Allison JE, Herrinton LJ.
    Am J Gastroenterol; 2007 Jul; 102(7):1429-35. PubMed ID: 17437504
    [Abstract] [Full Text] [Related]

  • 2. Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002.
    Herrinton LJ, Liu L, Lewis JD, Griffin PM, Allison J.
    Am J Gastroenterol; 2008 Aug; 103(8):1998-2006. PubMed ID: 18796097
    [Abstract] [Full Text] [Related]

  • 3. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN, Wajda A, Blanchard JF.
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423
    [Abstract] [Full Text] [Related]

  • 4. Validity of computerized diagnoses, procedures, and drugs for inflammatory bowel disease in a northern California managed care organization.
    Liu L, Allison JE, Herrinton LJ.
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1086-93. PubMed ID: 19672855
    [Abstract] [Full Text] [Related]

  • 5. Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study.
    Langer-Gould A, Albers KB, Van Den Eeden SK, Nelson LM.
    Mult Scler; 2010 Jul; 16(7):855-61. PubMed ID: 20463037
    [Abstract] [Full Text] [Related]

  • 6. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003.
    Hutfless SM, Weng X, Liu L, Allison J, Herrinton LJ.
    Gastroenterology; 2007 Dec; 133(6):1779-86. PubMed ID: 18054550
    [Abstract] [Full Text] [Related]

  • 7. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN, Wajda A, Blanchard JF.
    Gastroenterology; 2005 Sep; 129(3):827-36. PubMed ID: 16143122
    [Abstract] [Full Text] [Related]

  • 8. Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
    Gupta G, Gelfand JM, Lewis JD.
    Gastroenterology; 2005 Sep; 129(3):819-26. PubMed ID: 16143121
    [Abstract] [Full Text] [Related]

  • 9. Risk factors of colorectal cancer in inflammatory bowel disease.
    Bansal P, Sonnenberg A.
    Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
    [Abstract] [Full Text] [Related]

  • 10. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study.
    Shapiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A, Kremer E, Heymann A.
    J Am Acad Dermatol; 2007 Apr; 56(4):629-34. PubMed ID: 17157411
    [Abstract] [Full Text] [Related]

  • 11. Utilization of health care resources by individuals with inflammatory bowel disease in the United States: a profile of time since diagnosis.
    Longobardi T, Jacobs P, Bernstein CN.
    Am J Gastroenterol; 2004 Apr; 99(4):650-5. PubMed ID: 15089897
    [Abstract] [Full Text] [Related]

  • 12. Screening differences and risk of cervical cancer in inflammatory bowel disease.
    Hutfless S, Fireman B, Kane S, Herrinton LJ.
    Aliment Pharmacol Ther; 2008 Sep 01; 28(5):598-605. PubMed ID: 18549465
    [Abstract] [Full Text] [Related]

  • 13. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
    Ott C, Obermeier F, Thieler S, Kemptner D, Bauer A, Schölmerich J, Rogler G, Timmer A.
    Eur J Gastroenterol Hepatol; 2008 Sep 01; 20(9):917-23. PubMed ID: 18794607
    [Abstract] [Full Text] [Related]

  • 14. Inflammatory bowel disease in relation to contact allergy: a patient-based study.
    Engkilde K, Menné T, Johansen JD.
    Scand J Gastroenterol; 2007 May 01; 42(5):572-6. PubMed ID: 17454877
    [Abstract] [Full Text] [Related]

  • 15. Immune-mediated diseases in primary sclerosing cholangitis.
    Lamberts LE, Janse M, Haagsma EB, van den Berg AP, Weersma RK.
    Dig Liver Dis; 2011 Oct 01; 43(10):802-6. PubMed ID: 21700515
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for opportunistic infections in patients with inflammatory bowel disease.
    Toruner M, Loftus EV, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, Colombel JF, Egan LJ.
    Gastroenterology; 2008 Apr 01; 134(4):929-36. PubMed ID: 18294633
    [Abstract] [Full Text] [Related]

  • 17. Association of paediatric inflammatory bowel disease with other immune-mediated diseases.
    Kappelman MD, Galanko JA, Porter CQ, Sandler RS.
    Arch Dis Child; 2011 Nov 01; 96(11):1042-6. PubMed ID: 21903597
    [Abstract] [Full Text] [Related]

  • 18. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
    Makredes M, Robinson D, Bala M, Kimball AB.
    J Am Acad Dermatol; 2009 Sep 01; 61(3):405-10. PubMed ID: 19700012
    [Abstract] [Full Text] [Related]

  • 19. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases.
    Ardesjö B, Hansson CM, Bruder CE, Rorsman F, Betterle C, Dumanski JP, Kämpe O, Ekwall O.
    J Autoimmun; 2008 Jun 01; 30(4):273-82. PubMed ID: 18242955
    [Abstract] [Full Text] [Related]

  • 20. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.
    Gradel KO, Nielsen HL, Schønheyder HC, Ejlertsen T, Kristensen B, Nielsen H.
    Gastroenterology; 2009 Aug 01; 137(2):495-501. PubMed ID: 19361507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.